Calcitonin
🔹 What is Calcitonin?
Class: Naturally occurring peptide hormone secreted by the thyroid gland; salmon-derived calcitonin is the form most used clinically. Mechanism:
- Suppresses osteoclast activity, slowing the rate at which bone tissue is broken down.
- Promotes renal excretion of excess calcium, helping regulate serum calcium levels.
- Exerts a notable analgesic effect on bone-related pain, independent of its calcium-regulating action.
Primary focus:
- Bone health conditions such as osteoporosis, Paget’s disease, and hypercalcemia.
- Pain relief in acute bone events like vertebral compression fractures.
- Short-to-medium-term calcium regulation in hypercalcemia of malignancy.
🔹 Oral Dosage: Not effective; calcitonin is a peptide hormone and does not survive oral administration intact.
🔹 Nasal Spray Dosage (most common route) Range:
- Standard osteoporosis dosing is 200 IU daily via intranasal spray.
Frequency:
- Once daily, alternating nostrils is a common practice pattern.
Rationale: Nasal delivery is favored clinically for convenience and consistent absorption compared to injection, particularly for long-term osteoporosis management.
🔹 Injectable / Subcutaneous Dosage Range:
- 50–100 IU daily, adjusted to the condition being treated (hypercalcemia, Paget’s disease, fracture-related pain).
Frequency:
- Daily dosing during active treatment, with reassessment based on calcium levels and symptom response.
Rationale: Injectable dosing allows more direct, titratable control in situations where nasal delivery isn’t sufficient, such as acute hypercalcemia.
🔹 Cycle Length Common cycle length: Osteoporosis protocols are often long-term/maintenance in nature rather than short cycles. Off-cycle: Periodic reassessment of bone density and calcium markers is standard practice with prolonged use.
🔹 Optimal Dosing Window
- Nasal spray is typically used at the same time daily for consistency.
- No strong circadian rationale exists here; consistency matters more than specific timing.
✅ Educational Integration Example (nasal spray)
- Example protocol: 200 IU intranasal calcitonin daily, used long-term for osteoporosis management alongside calcium and vitamin D support.
- Commonly discussed alongside other bone-health-focused nutrients rather than GH or repair peptides.
🔹 Stacking Strategy (Educational / Complementary) Since calcitonin’s primary role is bone metabolism and calcium regulation, complementary support tends to focus on skeletal health broadly: 🔸 Bone & Mineral Support:
- Calcium and Vitamin D: Foundational cofactors for any bone-remodeling protocol involving calcitonin.
- Collagen peptides: Support the connective tissue matrix alongside calcitonin’s effect on bone turnover.
🔸 Recovery & Regeneration Support:
- BPC-157, TB-500: Complementary tissue repair support in fracture recovery contexts, working through different mechanisms than calcitonin’s calcium/osteoclast pathway.
Rationale: Calcitonin’s mechanism is narrow and calcium-focused, so stacking logic centers on reinforcing skeletal structure and healing rather than amplifying its own pathway.
Studied in Humans? Yes
FDA Approved? Yes — salmon calcitonin is FDA-approved (Miacalcin, Fortical) for osteoporosis in postmenopausal women, Paget's disease, and hypercalcemia.
Allowed for 503a Compounding Pharmacy? Yes — commonly compounded, particularly as a nasal spray formulation.
Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.